Pediatric Blood & Cancer

Papers
(The H4-Index of Pediatric Blood & Cancer is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Reply to: Comment on: Intravenous iron for critically ill children. Comparison of three dose regimens825045808
The COVID‐19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP‐E, SIOP‐PODC, IPSO, PROS, CCI, and St Jude Global98
COVID‐19 infection in children and adolescents with cancer in Madrid89
Osteosarcoma87
Early advice on managing children with cancer during the COVID‐19 pandemic and a call for sharing experiences80
How young patients with cancer perceive the COVID‐19 (coronavirus) epidemic in Milan, Italy: Is there room for other fears?75
Characterization of COVID‐19 disease in pediatric oncology patients: The New York‐New Jersey regional experience74
Children with cancer in the time of COVID‐19: An 8‐week report from the six pediatric onco‐hematology centers in Lombardia, Italy71
COVID‐19 and children with cancer: Parents’ experiences, anxieties and support needs70
COVID‐19 in pediatric oncology from French pediatric oncology and hematology centers: High risk of severe forms?67
Neuroblastoma59
Delayed cancer diagnoses and high mortality in children during the COVID‐19 pandemic58
Hematological manifestations of SARS‐CoV‐2 in children53
COVID‐19 in pediatric hematopoietic stem cell transplantation: The experience of Spanish Group of Transplant (GETMON/GETH)50
COVID‐19 anticoagulation recommendations in children49
The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis47
2023 ASPHO Conference Paper and Poster Index46
Clinical presentations and outcomes of children with cancer and COVID‐19: A systematic review43
COVID‐19 disease in New York City pediatric hematology and oncology patients42
ABSTRACTS40
Impacts of COVID‐19 on caregivers of childhood cancer survivors40
A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high‐grade glioma39
Financial toxicity of childhood cancer and changes to parents’ employment after treatment completion39
A collateral effect of the COVID‐19 pandemic: Delayed diagnosis in pediatric solid tumors38
Single‐center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia37
Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studi36
Wilms tumor36
The influence of nutrition on clinical outcomes in children with cancer36
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials35
Ewing sarcoma35
2020 ASPHO Conference Paper and Poster Index34
A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups34
ABSTRACTS33
0.053993940353394